2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

被引：13

作者：

Li, Philip Kam-Tao ^{[1
]}

Bavanandan, Sunita ^{[2
]}

Mohamed, Rosmawati ^{[3
]}

Szeto, Cheuk-Chun ^{[1
]}

Wong, Vincent Wai-Sun ^{[4
,5
]}

Chow, Kai-Ming ^{[1
]}

Dan, Yock-Young ^{[6
]}

Huang, Chiu-Ching ^{[7
,8
]}

Lai, Ching-Lung ^{[9
,10
]}

Tanwandee, Tawesak ^{[11
]}

Teo, Boon Wee ^{[12
]}

Wong, Grace Lai-Hung ^{[4
,5
]}

Yeoh, Eng-Kiong ^{[13
]}

Iseki, Kunitoshi ^{[14
]}

Leung, Chi-Bon ^{[1
]}

Park, Hyeong Cheon ^{[15
]}

Kanjanabuch, Talerngsak ^{[16
,17
]}

Lu, Wanhong ^{[18
]}

Fung, James ^{[8
,9
,10
]}

Jia, Jidong ^{[19
]}

Kanda, Eiichiro ^{[20
]}

Law, Man-Ching ^{[1
]}

Liu, Hong ^{[21
]}

Loo, Ching-Kong ^{[22
]}

Mak, Siu-Ka ^{[22
]}

Lui, Sing-Leung ^{[23
]}

Tang, Hon-Lok ^{[24
]}

Wang, Angela Yee-Moon ^{[9
]}

Yu, Ming-Lung ^{[25
,26
]}

Cheung, Michael ^{[27
]}

Jadoul, Michel ^{[28
]}

机构：

[1] Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Prince Wales Hosp, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China

[2] Hosp Kuala Lumpur, Dept Nephrol, Kuala Lumpur, Malaysia

[3] Univ Malaysia, Dept Med, Fac Med, Kuala Lumpur, Malaysia

[4] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[5] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[6] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore

[7] China Med Univ & Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan

[8] China Med Univ & Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan

[9] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[10] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China

[11] Mahidol Univ, Div Gastroenterol & Hepatol, Siriraj Hosp, Dept Internal Med,Fac Med, Bangkok, Thailand

[12] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Nephrol, Singapore, Singapore

[13] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China

[14] Tomishiro Cent Hosp, Okinawa, Japan

[15] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea

[16] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand

[17] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[18] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nephrol, Coll Med, Xian, Peoples R China

[19] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[20] Kawasaki Med Sch, Dept Med Sci, Okayama, Japan

[21] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China

[22] Kwong Wah Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[23] Tung Wah Hosp, Dept Med, Hong Kong, Peoples R China

[24] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[25] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[26] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[27] Kidney Dis Improving Global Outcomes KDIGO, Brussels, Belgium

[28] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

来源：

KIDNEY INTERNATIONAL REPORTS | 2020年 / 5卷 / 08期

关键词：

chronic kidney disease; dialysis; direct-acting antiviral; infection control; kidney transplantation; VIRUS-INFECTION; MICRO-ELIMINATION; DIALYSIS PATIENTS; CORE ANTIGEN; HEMODIALYSIS; DACLATASVIR; ASUNAPREVIR; SAFETY; EFFICACY; THERAPY;

D O I：

10.1016/j.ekir.2020.05.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

引用

页码：1129 / 1138

页数：10

共 50 条

[31] Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Swanepoel, Charles R.
Atta, Mohamed G.
D'Agati, Vivette D.
Estrella, Michelle M.
Fogo, Agnes B.
Naicker, Saraladevi
Post, Frank A.
Wearne, Nicola
Winkler, Cheryl A.
Cheung, Michael
Wheeler, David C.
Winkelmayer, Wolfgang C.
Wyatt, Christina M.
KIDNEY INTERNATIONAL, 2018, 93 (03) : 545 - 559
[32] KDIGO 2018 CLINICAL PRACTICE GUIDELINE FOR THE PREVENTION, DIAGNOSIS, EVALUATION, AND TREATMENT OF HEPATITIS C IN CHRONIC KIDNEY DISEASE
Wheeler, David C.
Winkelmayer, Wolfgang C.
KIDNEY INTERNATIONAL SUPPLEMENTS, 2018, 8 (03) : 91 - 165
[33] Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
de Boer, Ian H.
Khunti, Kamlesh
Sadusky, Tami
Tuttle, Katherine R.
Neumiller, Joshua J.
Rhee, Connie M.
Rosas, Sylvia E.
Rossing, Peter
Bakris, George
KIDNEY INTERNATIONAL, 2022, 102 (05) : 974 - 989
[34] Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
de Boer, Ian H.
Khunti, Kamlesh
Sadusky, Tami
Tuttle, Katherine R.
Neumiller, Joshua J.
Rhee, Connie M.
Rosas, Sylvia E.
Rossing, Peter
Bakris, George
DIABETES CARE, 2022, 45 (12) : 3075 - 3090
[35] Proteinuria Assessment and Therapeutic Implementation in Chronic Kidney Disease Patients-A Clinical Audit on KDIGO ("Kidney Disease: Improving Global Outcomes") Guidelines
Adelakun, Gabriela
Boesing, Maria
Mbata, Munachimso Kizito
Pasha, Zahra
Luthi-Corridori, Giorgia
Jaun, Fabienne
Burkhalter, Felix
Leuppi, Jorg D.
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
[36] Evidence Underlying KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Recommendations: A Systematic Review
Alseiari, Mohamed
Meyer, Klemens B.
Wong, John B.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (03) : 417 - 422
[37] Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Levey, Andrew S.
Eckardt, Kai-Uwe
Dorman, Nijsje M.
Christiansen, Stacy L.
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
KIDNEY MEDICINE, 2020, 2 (04) : 373 - 376
[38] Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
Andrew S. Levey
Kai-Uwe Eckardt
Nijsje M. Dorman
Stacy L. Christiansen
Michael Cheung
Michel Jadoul
Wolfgang C. Winkelmayer
Pediatric Nephrology, 2020, 35 : 2191 - 2200
[39] Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Levey, Andrew S.
Eckardt, Kai-Uwe
Dorman, Nijsje M.
Christiansen, Stacy L.
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
CLINICAL NEPHROLOGY, 2020, 94 (01) : 1 - 10
[40] Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
Levey, Andrew S.
Eckardt, Kai-Uwe
Dorman, Nijsje M.
Christiansen, Stacy L.
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
JOURNAL OF NEPHROLOGY, 2020, 33 (04) : 639 - 648

← 1 2 3 4 5 →